Opioid overdose deaths have reached record highs and emergency physicians have a vital role in potentially saving these patients by prescribing Medication Assisted Treatment (MAT) such as buprenorphine, and by prescribing naloxone, a rapid-acting medicine to reverse an overdose.
Meharry Medical College is one of four HBCUs partnering with the American Cancer Society.
New treatments, research and leadership - Middle Tennessee has a lot going on in oncology care.
Insights from a leading orthopedic trauma surgeon who recently visited Nashville for the Clinical Orthopaedic Society (COS) 2021 annual meeting in early November. Robert Harris, MD serves as First President-Elect for the COS.
Fanning the flames of emotional and physical pain, the global COVID-19 pandemic has added fuel to opioid use, driving the epidemic to new heights.
Substance use disorder knows no racial, economic, sexual orientation, age or gender boundaries. Fighting it requires a concerted effort on all fronts.
Nashville's unique treatment center is building stronger women and families by renewing hope.
The latest report from United Health Foundation finds areas of strength and opportunities for improvement in addressing health needs for women and children in Tennessee.
The Pulmonary Fibrosis Foundation (PFF) has issued a position statement that recommends healthcare providers address the incorporation of palliative care early in the medical journey of patients living with pulmonary fibrosis (PF).
An international phenomenon of involuntary movements and vocalizations in adolescent girls, similar to the tics seen in Tourette syndrome, is now believed to be a functional movement disorder.
Kenneth Ataga, MD, Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC), was recently awarded $3.2 million from the National Heart, Lung and Blood Institute for a project that enlists artificial intelligence in the fight against sickle cell disease.
Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).
A decade's worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.
Nurture the Next Discusses Ways to Help Children Cope as they Return to School
Over the course of the pandemic, researchers nationwide noticed differences in COVID-19 disease between children and adults.
National Medical Group Uses Systematic Professional Well-Being Approach to Support Clinicians' Wellness
Local healthcare leaders address the growing need for doctors nationwide
After enjoying a taste of 'return to normal' earlier this year, the Delta variant has changed the trajectory of the pandemic and plunged communities into crisis again.
New providers, centers and services give Middle Tennessee patients more option for pain relief and care.
The latest episode of the second season of Vanderbilt University Medical Center's original podcast series is up. Don't miss this discussion on breaking down barriers to care for Black and Brown communities
New data brief shows TN-4, TN-7, and TN-8 have among highest prevalence of Alzheimer's disease and related dementias among Black Americans in nation
The American Association for Cancer Research (AACR) announced the formation of its seventh and newest scientific working group, which will be dedicated to supporting cancer evolution research.
New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors
U.S. Senators Marsha Blackburn (R-Tenn.) and Dianne Feinstein (D-Calif.) today introduced the Protecting Access to Lifesaving Screenings (PALS) Act of 2021, a bill to preserve coverage for routine breast cancer screening for women beginning at age 40.
On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting amyloid for the treatment of Alzheimer's disease, including aducanumab, which was recently approved by the Food and Drug Administration (FDA).
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: